| Wissenschaftl. Titel | Open-label study to determine the efficacy and safety of pomalidomide (CC-4047) in combination with low dose Dexamethasone in subjects with relapsed or refractory multiple myeloma and moderate or severe renal impairment including subjects undergoing hemodialysis |
| Erkrankung |
Haema:
Multiples Myelom:
Zweitlinie oder später
|
| Kurzprotokoll | Kurzprotokoll |
| Links | Weiterführende Informationen (EudraCT) |
erstellt 12.11.2018 Data entry IX CCP
geändert 08.10.2020 Data entry XI CCP